Data updated: Mar 10, 2026
BSS PLUS
CALCIUM CHLORIDE
Ophthalmology
Approved 1981-10-28
1
Indication
--
Phase 3 Trials
44
Years on Market
Details
- Status
- Prescription
- First Approved
- 1981-10-28
- Routes
- IRRIGATION
- Dosage Forms
- SOLUTION
Companies
Active Ingredient: CALCIUM CHLORIDE , DEXTROSE , GLUTATHIONE DISULFIDE , MAGNESIUM CHLORIDE , POTASSIUM CHLORIDE , SODIUM BICARBONATE , SODIUM CHLORIDE , SODIUM PHOSPHATE
Website: โ
BSS PLUS Approval History
Loading approval history...
What BSS PLUS Treats
1 FDA approvalsOriginally approved for its first indication in 1981 .
- Other (1)
Other
(1 approval)- โข Approved indication (Oct 1981)
๐ฌ
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
โญ
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
๐
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
BSS PLUS FDA Label Details
ProIndications & Usage
FDA Label (PDF): BSS PLUS solution is indicated for use as an intraocular irrigating solution during intraocular surgical procedures involving perfusion of the eye.
Want competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
FDA Approval: NDA018469 โ Label: DailyMed โ Patents: FDA Orange Book โ Trials: ClinicalTrials.gov โ
Data sourced from official FDA and NIH databases. Click links to verify on original sources.